Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 05, 2021

SELL
$28.67 - $52.59 $917 - $1,682
-32 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$27.75 - $36.3 $333 - $435
-12 Reduced 27.27%
32 $1,000
Q2 2020

Aug 14, 2020

SELL
$27.21 - $41.0 $81 - $123
-3 Reduced 6.38%
44 $1,000
Q1 2020

May 14, 2020

BUY
$19.54 - $38.85 $918 - $1,825
47 New
47 $1,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.71B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Associated Banc Corp Portfolio

Follow Associated Banc Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Associated Banc Corp, based on Form 13F filings with the SEC.

News

Stay updated on Associated Banc Corp with notifications on news.